ABUS R&D Expenses
Arbutus Biopharma Corp · R&D Expenses
ABUS R&D Expenses
Latest reported$2.90Mperiod ending
ABUS Quarterly R&D Expenses ($950.05K → $2.90M)
Quarterly R&D Expenses
High-resolution chart · PNG
ABUS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 2,898,000 | |
| 4,120,000 | |
| 5,006,000 | |
| 5,778,000 | |
| 5,498,000 | |
| 8,959,000 | |
| 8,810,000 | |
| 14,273,000 | |
| 15,551,000 | |
| 15,403,000 | |
| 17,564,000 | |
| 20,169,000 | |
| 17,692,000 | |
| 18,275,000 | |
| 22,949,000 | |
| 20,055,000 | |
| 22,942,000 | |
| 18,462,000 | |
| 19,212,000 | |
| 16,709,000 | |
| 15,799,000 | |
| 13,782,000 | |
| 16,392,000 | |
| 12,065,000 | |
| 10,465,000 | |
| 10,416,000 | |
| 56,254,000 | |
| 17,731,000 | |
| 12,740,000 | |
| 14,712,000 | |
| 11,063,000 | |
| 16,566,000 | |
| 16,356,000 | |
| 13,949,000 | |
| 17,822,000 | |
| 15,537,000 | |
| 15,445,000 | |
| 13,872,000 | |
| 17,156,000 | |
| 15,738,000 | |
| 15,215,000 | |
| 13,144,000 | |
| 14,904,000 | |
| 16,354,000 | |
| 9,700,000 | |
| 10,557,000 | |
| 11,902,000 | |
| 9,309,000 | |
| 9,298,000 | |
| 8,204,000 | |
| 6,994,398 | |
| 5,497,367 | |
| 4,809,957 | |
| 4,116,967 | |
| 18,031,718,000,000 | |
| 3,148,965 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 22,133,977,938,338 | |
| 5,061,661 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 5,145,406 | |
| 5,569,549 | |
| 0 | |
| 3,049,702 | |
| 3,190,393 | |
| 950,045 |